| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |